Gregory Tintinger
Overview
Explore the profile of Gregory Tintinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mmakola K, Balmith M, Steel H, Said M, Potjo M, van der Mescht M, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684733
Multidrug-resistant tuberculosis (MDR-TB) patients are treated with a standardised, short World Health Organization (WHO) regimen which includes clofazimine (CFZ) and bedaquiline (BDQ) antibiotics. These two antibiotics lead to the development...
2.
Repsold L, Pool R, Karodia M, Tintinger G, Joubert A
Microsc Res Tech
. 2022 Feb;
85(6):2222-2233.
PMID: 35174933
Chronic myeloid leukemia (CML) is a myeloproliferative disease and the first line treatment is through the administration of Imatinib, a first generation tyrosine kinase inhibitor. Thrombocytosis and bleeding irregularities are...
3.
Hendricks C, Herd C, Nel M, Tintinger G, Pepper M
Front Med (Lausanne)
. 2021 Mar;
8:604087.
PMID: 33681243
The pandemic caused by SARS-CoV-2 has infected more than 94 million people worldwide (as of 17 January 2020). Severe disease is believed to be secondary to the cytokine release syndrome...
4.
Repsold L, Pool R, Karodia M, Tintinger G, Becker P, Joubert A
Cell Biochem Funct
. 2021 Feb;
39(4):562-570.
PMID: 33569808
Chronic myeloid leukaemia (CML) is a malignancy of the haematopoietic stem cells. The first line of treatment for CML, especially in developing countries, remains the first-generation tyrosine kinase inhibitor, Imatinib....
5.
Meyer P, Ally M, Tikly M, Tintinger G, Winchow L, Steel H, et al.
Mediators Inflamm
. 2019 Nov;
2019:4693870.
PMID: 31780859
Microbial lipopolysaccharides (LPS) have been implicated in the pathogenesis of rheumatoid arthritis (RA), possibly driving a systemic inflammatory response that may trigger the development and/or exacerbation of the disease. To...
6.
Richards G, Theron A, Tintinger G, Anderson R
Pharmaceuticals (Basel)
. 2018 May;
11(2).
PMID: 29758017
Dabigatran is an oral direct thrombin inhibitor, and rivaroxaban, a factor Xa inhibitor. Dabigatran has been implicated in the etiology of acute coronary syndromes and as these occur following inflammatory...
7.
Repsold L, Pool R, Karodia M, Tintinger G, Joubert A
Cancer Cell Int
. 2017 Nov;
17:89.
PMID: 29118670
Amongst males, leukaemia is the most common cause of cancer-related death in individuals younger than 40 years of age whereas in female children and adolescents, leukaemia is the most common...
8.
Anderson R, Tintinger G, Cockeran R, Potjo M, Feldman C
Pharmaceuticals (Basel)
. 2016 Oct;
3(5):1694-1710.
PMID: 27713324
In general antibiotics interact cooperatively with host defences, weakening and decreasing the virulence of microbial pathogens, thereby increasing vulnerability to phagocytosis and eradication by the intrinsic antimicrobial systems of the...